Yunnan Baiyao Group Co.,Ltd (SZSE: 000538)
Health Care · Pharmaceuticals · CN
CN¥49.33
-1.40% today · -14.9% 1Y
Yunnan Baiyao Group Co.,Ltd (SZSE: 000538) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $13.09B and employs 9,286 people.
Over the last twelve months the share price has lost 14.9%, trading between 46.29 and 60.69.
Tweenvest scores Yunnan Baiyao Group Co.,Ltd across four factors: quality 83/100, value 80/100, growth 50/100, dividend 90/100. Its strongest factor is dividend.
000538 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $13.09B
- Revenue (TTM)
- $6.08B
- P/E
- 16.73
- EPS
- 2.95
- Dividend yield
- 5.27%
- Beta (5Y)
- 0.10
- 52-week high
- CN¥60.69
- 52-week low
- CN¥46.29
- Avg volume (3M)
- —
- Shares outstanding
- 1.78B
- Employees
- 9,286
- Next earnings
- —
About Yunnan Baiyao Group Co.,Ltd
Operating globally and domestically within China, Yunnan Baiyao Group Co., Ltd. specializes in the pharmaceutical industry. Its diverse portfolio encompasses health supplements, a wide array of medications, medical devices, traditional Chinese medicine ingredients, and even tea. These offerings are marketed under various brand identities, including Yunnan Baiyao, Yunfeng, Tong Qiaoqiao, Yunjian, Life, Jinkoujian, Langjian, Yangyuanqing, Caizhiji, Baiyao Health, Leopard Seven, Qiancaotang, Qiancao Meizi, and Tianzihong. The company, established in 1902, maintains its principal offices in Kunming, China.
- ISIN
- CNE0000008X7
- Founded
- 1902
- Listed since
- Dec 15, 1993
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,256.19 | +0.06% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.00 | +0.28% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $153.00 | +0.29% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.30 | -1.41% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.00 | -1.14% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.13 | +0.21% |
Figures last refreshed Aug 18, 2026.